A polysomnography study of eszopiclone in elderly patients with insomnia

References

• Roth T. New developments for treating sleep disorders. J Clin Psychiatry 2001;62(Suppl 10):3–4
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22\(Suppl 2):S347–S353
   Google Scholar
• Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc 2000;48: 1234–40
   Google Scholar
• Avidan AY, Fries BE, James ML, et al. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955–62
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000;23(Suppl 1):S23–S30
   PubMed Web of Science ®Google Scholar
• Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22 (Suppl 2):S386–S393
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders – text revision, 4th ed. Washington (DC): American Psychiatric Publishing Inc.; 2000
   Google Scholar
• Hohagen F, Kappler C, Schramm E, et al. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening – temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994:17:551–4
   PubMed Web of Science ®Google Scholar
• Reynolds III CF. Sleep disorders. In: Sadavoy J, Lazarus LW, Jarvik LF, Grossberg GT, editors. Comprehensive review of geriatric psychiatry – II. Washington (DC): American Psychiatric Press Inc.; 1996. p. 693–712
   Google Scholar
• Webb WB. Sleep in older persons: sleep structures of 50- to 60-year-old men and women. J Gerontol 1982;37:581–6
   PubMedGoogle Scholar
• McCall WV. Management of primary sleep disorders among elderly persons. Psychiatr Serv 1995;46:49–55
   PubMed Web of Science ®Google Scholar
• Morin CM, Mimeault V, Gagne A. Nonpharmacological treatment of late-life insomnia. J Psychosom Res 1999;46:103–16
   Google Scholar
• Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425–32
   PubMed Web of Science ®Google Scholar
• Cornomi-Huntley JC, Ostfeld AM, Taylor JO, et al. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging Clin Exp Res 1993;5:27–37
   Google Scholar
• Metz ME, Bunnell DE. Napping and sleep disturbances in the elderly. Fam Pract Res J 1990;10:47–56
   PubMedGoogle Scholar
• Hedner J, Yaeche R, Emilien G, et al. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia [The Zaleplon Clinical Investigator Study Group]. Int J Geriatr Psychiatry 2000;15:704–12
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Walsh JK, Mangano RM, et al. Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiatry 1999;1:114–20
   Google Scholar
• Leppik IE, Roth-Schechter GB, Gray GW, et al. Double-blind, placebo-controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia. Drug Dev Res 1997;40:230–8
   Web of Science ®Google Scholar
• Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 1992;20:150–61
   Google Scholar
• Roth TG, Roehrs TA, Koshorek GL, et al. Hypnotic effects of low doses of quazepam in older insomniacs. J Clin Psychopharmacol 1997;17:401–6
   PubMed Web of Science ®Google Scholar
• Roehrs T, Zorick F, Wittig R, et al. Efficacy of a reduced triazolam dose in elderly insomniacs. Neurobiol Aging 1985;6:293–6
   PubMed Web of Science ®Google Scholar
• Zammit G, Gillin JC, McNabb L, et al. Eszopiclone, a novel non-benzodiazepine anti-insomnia agents: a six-week efficacy and safety study in adult patients with chronic insomnia. Sleep 2003;26:A29
   Web of Science ®Google Scholar
• Krystal A, Walsh J, Roth T, et al. The sustained efficacy and safety of eszopiclone over six months of nightly treatment: a placebo-controlled study in patients with chronic insomnia. Sleep 2003;6:783–99
   Google Scholar
• Maier G, Rubens R, Amato D. Pharmacokinetic and pharmaco-dynamic effects of eszopiclone: a comparison of healthy non-elderly and elderly adults. Sleep 2004;27(Suppl):A56 [abstract]
   Google Scholar
• Scharf M, Erman M, Rosenberg R, et al. A two-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep 2005;28:720–7
   PubMed Web of Science ®Google Scholar
• Dickel MJ, Mosko SS. Morbidity cut-offs for sleep apnea and periodic leg movements in predicting subjective complaints in seniors. Sleep 1990;13:155–66
   PubMed Web of Science ®Google Scholar
• Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307
   Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. The SF-36 health survey manual and interpretation guide. Boston (MA): Nimrod Press; 1995
   Google Scholar
• Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects [Public Health Service, NIH Publication No. 204]. Washington (DC): US Government Printing Office; 1968
   Google Scholar
• Conover WJ. Practical nonparametric statistics, 3rd ed. New York (NY): John Wiley & Sons; 1998
   Google Scholar
• Roth T, Ancoli Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey II. Sleep 1999;22(Suppl 2):S354–S358
   PubMed Web of Science ®Google Scholar
• Roth T, Walsh JK, Krystal A, et al. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 20056:487–95
   Google Scholar